Medicare Enrolled

Dr. Pedro Garciarena, M.D.

Behavioral Neurology & Neuropsychiatry Physician · Naples, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3200 BAILEY LN STE 200, Naples, FL 34105
2392628971
Registered in NPPES since 2008
NPI: 1508038431 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garciarena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garciarena? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garciarena

Dr. Pedro Garciarena is a behavioral neurology & neuropsychiatry physician in Naples, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Garciarena performed 8,044 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Garciarena received a total of $12,456 from 75 pharmaceutical and/or device companies across 585 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garciarena is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 11% volume in FL $12,456 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 114580 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
8,044
Medicare services
Top 11% in FL for behavioral neurology & neuropsychiatry physician
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection (Xeomin), per unit
An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit.
7,626 $4 $12
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
130 $103 $334
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
90 $146 $461
New patient office visit, complex (60-74 min) 78 $176 $562
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 39 $63 $208
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $136 $423
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
27 $181 $769
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
25 $135 $442
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,456
Total received (2018-2024)
Avg $1,779/year across 7 years
Top 11% in FL for behavioral neurology & neuropsychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
585
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,789
2023
$1,657
2022
$663
2021
$1,222
2020
$505
2019
$2,194
2018
$2,424

Payments by company (2024)

ABBVIE INC.
$711
UCB, Inc.
$486
Alexion Pharmaceuticals, Inc.
$333
Eisai Inc.
$295
Teva Pharmaceuticals USA, Inc.
$259
Novartis Pharmaceuticals Corporation
$236
Alnylam Pharmaceuticals Inc.
$172
Novocure Inc.
$154
SCILEX PHARMACEUTICALS INC.
$145
Amneal Pharmaceuticals LLC
$133
Lilly USA, LLC
$117
ARGENX US, INC.
$89
Merz Pharmaceuticals, LLC
$79
MDD US Operations, LLC
$62
Lundbeck LLC
$59
Neurocrine Biosciences, Inc.
$58
PFIZER INC.
$51
Xeris Pharmaceuticals, Inc.
$48
ACADIA Pharmaceuticals Inc
$42
Sumitomo Pharma America, Inc.
$41
Neurelis, Inc.
$38
GE HEALTHCARE
$36
GENZYME CORPORATION
$35
Otsuka America Pharmaceutical, Inc.
$24
Kyowa Kirin, Inc.
$23
AstraZeneca Pharmaceuticals LP
$22
Vanda Pharmaceuticals Inc.
$21
Abbott Laboratories
$20
Top 3 companies account for 40.4% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,195
Sunovion Pharmaceuticals Inc.
$979
ABBVIE INC.
$816
Teva Pharmaceuticals USA, Inc.
$774
Amgen Inc.
$761
Novartis Pharmaceuticals Corporation
$651
Alexion Pharmaceuticals, Inc.
$572
Acorda Therapeutics, Inc
$422
Eisai Inc.
$400
Lilly USA, LLC
$379
Allergan Inc.
$378
ACADIA Pharmaceuticals Inc
$353
Alnylam Pharmaceuticals Inc.
$310
Avanir Pharmaceuticals, Inc.
$299
Takeda Pharmaceuticals U.S.A., Inc.
$286
Neurocrine Biosciences, Inc.
$280
PFIZER INC.
$262
Amneal Pharmaceuticals LLC
$191
SCILEX PHARMACEUTICALS INC.
$166
Novocure Inc.
$154
Celgene Corporation
$139
Allergan, Inc.
$135
GENZYME CORPORATION
$133
Biogen, Inc.
$132
Biohaven Pharmaceutical Holding Company Ltd.
$125
Greenwich Biosciences, Inc.
$121
Lundbeck LLC
$111
US WorldMeds, LLC
$104
Neurelis, Inc.
$104
Mitsubishi Tanabe Pharma America, Inc.
$99
MDD US Operations, LLC
$89
ARGENX US, INC.
$89
Sumitomo Pharma America, Inc.
$84
Horizon Therapeutics plc
$80
Merz Pharmaceuticals, LLC
$79
Scilex Pharmaceuticals Inc.
$65
Kyowa Kirin, Inc.
$63
GE Healthcare
$63
Biohaven Pharmaceuticals, Inc.
$63
Mallinckrodt Hospital Products Inc.
$63
UPSHER-SMITH LABORATORIES LLC
$61
GE HEALTHCARE
$49
Xeris Pharmaceuticals, Inc.
$48
Supernus Pharmaceuticals, Inc.
$44
ARBOR PHARMACEUTICALS, INC.
$41
TerSera Therapeutics LLC
$38
Averitas Pharma Inc.
$34
IMPEL PHARMACEUTICALS INC.
$33
JAZZ PHARMACEUTICALS INC.
$30
Janssen Pharmaceuticals, Inc
$27
GRT US Holding, Inc.
$26
Impax Laboratories, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$24
Avion Pharmaceuticals
$24
Ipsen Biopharmaceuticals, Inc
$24
E.R. Squibb & Sons, L.L.C.
$24
AstraZeneca Pharmaceuticals LP
$22
Vanda Pharmaceuticals Inc.
$21
Ceribell, Inc.
$20
Abbott Laboratories
$20
TG THERAPEUTICS, INC.
$19
Ironwood Pharmaceuticals, Inc
$19
Almatica Pharma LLC
$19
SK Life Science, Inc.
$19
Mallinckrodt LLC
$18
AbbVie Inc.
$18
Janssen Biotech, Inc.
$18
RedHill Biopharma Inc.
$18
Axonics, Inc.
$17
GE HealthCare
$17
Merck Sharp & Dohme Corporation
$15
Harmony Biosciences LLC
$14
EMD Serono, Inc.
$14
Collegium Pharmaceutical, Inc.
$14
LivaNova USA, Inc.
$14
Top 3 companies account for 24.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · Axonics · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CHANTIX · COPAXONE · CREXONT · Ceribell Rapid Response EEG · DUOPA · DYSPORT · Dhivy · EMGALITY · ENTYVIO · ERGOMAR · Epidiolex · Fintepla · Fycompa · GILENYA · GRALISE · Gocovri · Horizant · I-STAT · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LYRICA · Leqembi · Linzess · MAYZENT · MYOBLOC · Movantik · NAMZARIC · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA Xsail · Ongentys · Optune · PONVORY · Ponvory · QULIPTA · QUTENZA · Qutenza · REMICADE · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SUNOSI · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XTAMPZA · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a behavioral neurology & neuropsychiatry physician in Naples?
Compare behavioral neurology & neuropsychiatry physicians in the Naples area by procedure volume, costs, and industry payment transparency.
Browse behavioral neurology & neuropsychiatry physicians nearby

Geographic Context

Behavioral neurology & neuropsychiatry physicians in nearby ZIP areas
1
County median income
$86,173
Nearest hospital to ZIP centroid (approximate)
NAPLES COMMUNITY HOSPITAL
4.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Garciarena is a mixed practice specialist, with above-average Medicare volume (top 11% in FL), with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Garciarena experienced with botox injection (xeomin), per unit?
Based on Medicare claims data, Dr. Garciarena performed 7,626 botox injection (xeomin), per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Garciarena receive payments from pharmaceutical companies?
Yes. Dr. Garciarena received a total of $12,456 from 75 companies across 585 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garciarena's costs compare to other behavioral neurology & neuropsychiatry physicians in Naples?
Dr. Garciarena's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garciarena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →